 The consortium included banker Jacob Wallenberg, and the Wallenberg family since continued to have a stake in the company.Under long-serving CEO Börje Gabrielsson, who led the company until 1957, Astra showed profit from 1929 and grew continuously.In the 1930s, Astra started to conduct its own research, initially on a very small scale, rather than just manufacturing existing pharmaceutical preparations.